Roy W. Beck

61.6k total citations · 23 hit papers
391 papers, 33.4k citations indexed

About

Roy W. Beck is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Roy W. Beck has authored 391 papers receiving a total of 33.4k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Endocrinology, Diabetes and Metabolism, 145 papers in Surgery and 123 papers in Genetics. Recurrent topics in Roy W. Beck's work include Diabetes Management and Research (200 papers), Pancreatic function and diabetes (129 papers) and Diabetes and associated disorders (122 papers). Roy W. Beck is often cited by papers focused on Diabetes Management and Research (200 papers), Pancreatic function and diabetes (129 papers) and Diabetes and associated disorders (122 papers). Roy W. Beck collaborates with scholars based in United States, Canada and Germany. Roy W. Beck's co-authors include Aaron T. Beck, Richard M. Bergenstal, William V. Tamborlane, David M. Maahs, Frederick L. Ferris, Neil M. Bressler, Adam R. Glassman, Kellee M. Miller, Katrina J. Ruedy and Linda A. DiMeglio and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Roy W. Beck

378 papers receiving 31.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening Depressed Patients in Family Practice

1972 1.6k citations Roy W. Beck et al. profile →
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

2019 1.4k citations Roy W. Beck, Mark A. Clements et al. Diabetes Technology & Therapeutics profile →
Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

2000 1.1k citations Roy W. Beck et al. profile →
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

2010 1.1k citations Lloyd Paul Aiello, Roy W. Beck et al. Ophthalmology profile →
Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

2015 983 citations Roy W. Beck, Richard M. Bergenstal et al. profile →
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis

1992 849 citations Roy W. Beck, Mark J. Kupersmith et al. profile →
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

2017 838 citations Roy W. Beck, Katrina J. Ruedy et al. profile →
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

2016 710 citations Adam R. Glassman, Roy W. Beck et al. Ophthalmology profile →
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

2015 529 citations Adam R. Glassman, Lloyd Paul Aiello et al. profile →
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

2018 528 citations Roy W. Beck, Richard M. Bergenstal et al. profile →
Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema

2006 469 citations David J. Browning, Adam R. Glassman et al. Ophthalmology profile →
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

2018 462 citations Richard M. Bergenstal, Roy W. Beck et al. profile →
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections

2017 449 citations Roy W. Beck, Katrina J. Ruedy et al. profile →
Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

2011 430 citations Roy W. Beck, Adam R. Glassman et al. Ophthalmology profile →
Hopelessness, Depression, and Attempted Suicide

1973 408 citations Roy W. Beck et al. profile →
Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants

2013 364 citations Kellee M. Miller, Roy W. Beck et al. profile →
The T1D Exchange Clinic Registry

2012 346 citations Roy W. Beck, William V. Tamborlane et al. The Journal of Clinical Endocrinology & Metabolism profile →
The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading

2017 334 citations Roy W. Beck, Richard M. Bergenstal et al. profile →
The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c

2019 324 citations Roy W. Beck, Richard M. Bergenstal et al. Journal of Diabetes Science and Technology profile →
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

2020 284 citations Marc D. Breton, Lauren Kanapka et al. profile →
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes

2020 268 citations Lauren Kanapka, Roy W. Beck et al. profile →
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

2018 262 citations Adam R. Glassman, Andrew N. Antoszyk et al. profile →
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes

2023 81 citations Bruce A. Buckingham, Gregory P. Forlenza et al. profile →

Peers

Countries citing papers authored by Roy W. Beck

Since Specialization

Citations

This map shows the geographic impact of Roy W. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy W. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy W. Beck more than expected).

Fields of papers citing papers by Roy W. Beck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy W. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy W. Beck. The network helps show where Roy W. Beck may publish in the future.

Co-authorship network of co-authors of Roy W. Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Roy W. Beck. A scholar is included among the top collaborators of Roy W. Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy W. Beck. Roy W. Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development 2025 ·Diabetologia ·Peter Calhoun, (unknown), Andrea K. Steck, Brigitte I. Frohnert, Mark A. Herman, Bart Keymeulen, Riitta Veijola, Jorma Toppari, (unknown), Frans Gorus, Mark A. Atkinson, Darrell M. Wilson, Susan L. Pietropaolo, Roy W. Beck	0
2	Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems 2025 ·Journal of Diabetes Science and Technology ·Richard M. Bergenstal, Adam Heller, Marc D. Breton, Robert A. Vigersky, Susan A. Brown, Gregory P. Forlenza, Jennifer L. Sherr, Roman Hovorka, Steven J. Russell, Edward R. Damiano, Melissa S. Putman, Roy W. Beck, Éric Renard, Rayhan Lal, Claudio Cobelli, Eyal Dassau, Halis Kaan Aktürk, Michael A. Weiss, Jay S. Skyler	1
3	Registration and Real-Life Studies on Automated Insulin Delivery Systems 2025 ·Journal of Diabetes Science and Technology ·Halis Kaan Aktürk, Sue A. Brown, Roy W. Beck, Jennifer L. Sherr, Richard M. Bergenstal, Boris Kovatchev, Robert A. Vigersky, Marc D. Breton, Roman Hovorka, David C. Klonoff, (unknown)	3
4	Automated Insulin Delivery in Elderly with Type 1 Diabetes: A Prespecified Analysis of the Extension Phase 2025 ·Diabetes Technology & Therapeutics ·Yogish C. Kudva, Robert J. Henderson, Lauren Kanapka, Ruth S. Weinstock, Michael R. Rickels, Richard E. Pratley, Naomi Chaytor, (unknown), Donna Desjardins, Vishwanath Pattan, Amy J. Peleckis, Anna Casu, (unknown), Suzan Bzdick, (unknown), (unknown), Kellee M. Miller, Craig Kollman, Roy W. Beck, (unknown)	0
5	Observed Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A 6-Month Analysis 2024 ·The Journal of Clinical Endocrinology & Metabolism ·John B. Tillman, Roy W. Beck, William H. Polonsky, Peter Calhoun, Thomas J. Mouse, Ryan Bailey, Jeanne L. Jacoby, Rakesh Nandan, (unknown), James Malone	1
6	Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort 2024 ·Diabetologia ·(unknown), (unknown), Robin L. Gal, Peter Calhoun, Zoey Li, Peter G. Jacobs, Mark A. Clements, Corby K. Martin, Francis J. Doyle, Susana R. Patton, Jessica R. Castle, Melanie B. Gillingham, Roy W. Beck, Michael R. Rickels, Michael C. Riddell, (unknown)	2
7	63-OR: Continuous Glucose Monitoring Prediction of Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes 2024 ·Diabetes ·(unknown), Roy W. Beck, Celeste Durnwald, Anders L. Carlson, (unknown), Richard M. Bergenstal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
8	Use of the Community-Derived Open-Source Automated Insulin Delivery Loop System in Type 2 Diabetes 2024 ·Diabetes Technology & Therapeutics ·(unknown), Lauren Kanapka, (unknown), Rayhan Lal, (unknown), Roy W. Beck	4
9	Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity 2023 ·Journal of American Association for Pediatric Ophthalmology and Strabismus ·David K. Wallace, Amra Hercinovic, Sharon F. Freedman, Eric R. Crouch, Amit Bhatt, M. Elizabeth Hartnett, Michael B. Yang, David L. Rogers, Amy K. Hutchinson, William V. Good, Michael X. Repka, Zhuokai Li, Roy W. Beck, Raymond T. Kraker, Susan A. Cotter, Jonathan M. Holmes	5
10	The Type 1 Diabetes and EXercise Initiative: Predicting Hypoglycemia Risk During Exercise for Participants with Type 1 Diabetes Using Repeated Measures Random Forest 2023 ·Diabetes Technology & Therapeutics ·(unknown), Michael C. Riddell, Peter G. Jacobs, Zoey Li, Robin L. Gal, Mark A. Clements, Francis J. Doyle, Corby K. Martin, Susana R. Patton, Jessica R. Castle, Melanie B. Gillingham, Roy W. Beck, Michael R. Rickels, Peter Calhoun, (unknown)	12
11	Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial 2023 ·Diabetes Technology & Therapeutics ·Georgia M. Davis, Michael S. Hughes, Sue A. Brown, Judy Sibayan, M. Citlalli Perez‐Guzman, (unknown), Zachary Thompson, Marina Basina, Ronak M. Patel, (unknown), (unknown), Trang T. Ly, (unknown), Marilyn Tan, Liana Hsu, Craig Kollman, Roy W. Beck, Rayhan Lal, Bruce A. Buckingham, Francisco J. Pasquel	19
12	Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry 2018 ·Pediatric Diabetes ·William V. Tamborlane, Pei-Yao Chang, Craig Kollman, Georgeanna J. Klingensmith, Katrina J. Ruedy, Robin L. Gal, Michelle Van Name, Fida Bacha, Steven M. Willi, Roy W. Beck	11
13	A Randomized Trial of Levodopa as Treatment for Residual Amblyopia in Older Children 2015 ·Ophthalmology ·Michael X. Repka, Raymond T. Kraker, Trevano W. Dean, Roy W. Beck, R. Michael Siatkowski, Jonathan M. Holmes, Cynthia L. Beauchamp, Richard P. Golden, Aaron M. Miller, Lisa C. Verderber, David K. Wallace	42
14	The Effects of Inpatient Hybrid Closed-Loop Therapy Initiated Within 1 Week of Type 1 Diabetes DiagnosisDiabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups 2013 ·Diabetes Technology & Therapeutics ·(unknown), (unknown), Bruce A. Buckingham, Roy W. Beck, Katrina J. Ruedy, Peiyao Cheng, Craig Kollman, Stuart A. Weinzimer, Linda A. DiMeglio, Andrew A. Bremer	15
15	A Randomized Trial Comparing Bangerter Filters and Patching for the Treatment of Moderate Amblyopia in Children 2010 ·Ophthalmology ·(unknown), ROBERT P. RUTSTEIN, Graham E. Quinn, Elizabeth L. Lazar, Roy W. Beck, Dean J. Bonsall, Susan A. Cotter, Eric R. Crouch, Jonathan M. Holmes, Darren L. Hoover, David A. Leske, (unknown), Michael X. Repka	110
16	Visual function at baseline and 1 month in acute optic neuritis: Predictors of visual outcome 2008 ·Neurology ·Mark J. Kupersmith, Robin L. Gal, Roy W. Beck, Neil R. Miller, New York	6
17	Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age 2008 ·Journal of American Association for Pediatric Ophthalmology and Strabismus ·(unknown), Michael X. Repka, B. Michele Melia, Roy W. Beck, (unknown), (unknown), Jonathan M. Holmes, (unknown), David G. Morrison, Graham E. Quinn, David I. Silbert, Benjamin H. Ticho, David K. Wallace	58
18	Continuous Glucose Monitoring in Children with Type 1 Diabetes 2007 ·The Journal of Pediatrics ·(unknown), Bruce A. Buckingham, Roy W. Beck, William V. Tamborlane, Dongyuan Xing, Craig Kollman, Rosanna Fiallo‐Scharer, Nelly Mauras, Katrina J. Ruedy, Michael Tansey, Stuart A. Weinzimer	107
19	Diurnal Variation in Retinal Thickening Measurement by Optical Coherence Tomography in Center-Involved Diabetic Macular Edema 2006 ·Archives of Ophthalmology ·(unknown), Ronald P. Danis, Adam R. Glassman, Lloyd Paul Aiello, Andrew N. Antoszyk, Roy W. Beck, David J. Browning, Antonio P. Ciardella, James L. Kinyoun, T. Murtha, Trexler M. Topping, Michel Shami, George S. Sharuk	49
20	Is Donor Age an Important Determinant of Graft Survival? 1999 ·Cornea ·Roy W. Beck, Robin L. Gal, Mark J. Mannis, Edward J. Holland, (unknown), Gary N. Foulks, Ellen Heck, Thomas Lindquist, Marian S. Macsai, Ronald E. Smith, Walter J. Stark, Elmer Y. Tu, Joel Sugar	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact